DXCM — DexCom Inc. Stock Price, Chart & Financials

DXCM

DexCom Inc.Stock · HealthcareNasdaq-100 0.1% · S&P 500 0.0%

$71.54+$1.06 (+1.50%)as of market close, Jul 24, 2026

CompareLLYUNHJNJABBVISRGABT

What would $1,000 invested in DXCM be worth today? →

DXCM returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $71.54
Change YTD: +7.51%
Next earnings: Jul 30, 2026 · After close
Market cap: 27.6B
Enterprise value: 26.5B
Shares outstanding: 385.9M
52W low: $54.11
52W high: $89.98
From 52W high: -20.49%
From 52W low: +32.21%
52W range: 49%
Beta: 1.45

Volume

Rel volume: 0.89×
30D volume: 4.6M
30D $ vol: 333.3M

Fundamentals

Sales (ttm): 4.8B
Sales/share: $12.49
EPS (ttm): $2.36
FCF (ttm): 1.4B
FCF/share: $3.70
Book value/share: $7.66
Net margin: 19.31%
ROE: 31.47%
ROA: 14.03%
Debt / equity: 0.00×
Current ratio: 1.95

Growth (CAGR, ttm) · 10Y

Sales: +26.89%
Net income: n/a
FCF: +66.76%
Shares: +1.46%

Per-share growth (CAGR, ttm) · 10Y

EPS: n/a
Sales/share: +25.06%
FCF/share: +64.36%
Book value/share: +27.17%
Price: +12.52%
Total return: +12.52%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm): 29.7×
Fwd P/E: 22.7×
P/S (ttm): 5.7×
P/B (mrq): 9.3×
P/FCF (ttm): 19.3×
EV/EBITDA (fy): 22.8×
EV/Sales (ttm): 5.5×
FCF yield (ttm): 5.18%
Buyback yield (ttm): 1.71%
Shareholder yield (ttm): 1.71%

Vs own 10Y history

P/E: 3rd
P/S: 5th
P/B: 4th
P/FCF: 2nd

Bar = where today's multiple sits in DXCM's own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance

+1.50%

-6.67%

+2.57%

+14.10%

YTD

+7.51%

-17.23%

-36.22%

Financial statements

Open full DXCM financials →

Related Healthcare

Ticker	Theme	Price	1M	30D $Vol
LLY Eli Lilly and Company	Pharmaceuticals	$1,196	+7.05%	3.2B
JNJ Johnson & Johnson	Pharmaceuticals	$263	+9.30%	2.1B
ABBV AbbVie Inc.	Biopharma	$259	+10.36%	1.9B
UNH UnitedHealth Group Incorporated Common Stock (DE)		$421	+3.66%	2.6B
MRK Merck & Co. Inc.	Pharmaceuticals	$131	+8.70%	1.3B
TMO Thermo Fisher Scientific Inc.	Life Sciences	$568	+15.45%	1.1B
AMGN Amgen Inc.	Biotech	$376	+7.00%	969.4M
ABT Abbott Laboratories	Medical Devices	$103	+13.95%	1.3B

DexCom Inc. (DXCM) trades at $71.54 with a live price and an interactive chart covering 21+ years of daily price history, plus key valuation metrics. ChartRow also publishes DXCM's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full DXCM financial statements →

DXCM — DexCom Inc. stock price, chart and key statistics